Literature DB >> 17077287

Acquisition of in vitro and in vivo functionality of Nurr1-induced dopamine neurons.

Chang-Hwan Park1, Jin Sun Kang, Yeon Ho Shin, Mi-Yoon Chang, Seungsoo Chung, Hyun-Chul Koh, Mei Hong Zhu, Seog Bae Oh, Yong-Sung Lee, Georgia Panagiotakos, Vivian Tabar, Lorenz Studer, Sang-Hun Lee.   

Abstract

Neural precursor cells provide an expandable source of neurons and glia for basic and translational applications. However, little progress has been made in directing naive neural precursors toward specific neuronal fates such as midbrain dopamine (DA) neurons. We have recently demonstrated that transgenic expression of the nuclear orphan receptor Nurr1 is sufficient to drive dopaminergic differentiation of forebrain embryonic rat neural precursors in vitro. However, Nurr1-induced DA neurons exhibit immature neuronal morphologies and functional properties and are unable to induce behavioral recovery in rodent models of Parkinson's disease (PD). Here, we report on the identification of key genetic factors that drive morphological and functional differentiation of Nurr1-derived DA neurons. We show that coexpression of Nurr1, Bcl-XL, and Sonic hedgehog (SHH) or Nurr1 and the proneural bHLH factor Mash1 is sufficient to drive naive rat forebrain precursors into neurons exhibiting the biochemical, electrophysiological, and functional properties of DA neuron in vitro. On transplantation into the striatum of Parkinsonian rats, precursor cells engineered with Nurr1/SHH/Bcl-XL or Nurr1/Mash1 survived in vivo and differentiated into mature DA neurons that can reverse the behavioral deficits in the grafted animals.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17077287     DOI: 10.1096/fj.06-6159fje

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  19 in total

Review 1.  Nurr1-Based Therapies for Parkinson's Disease.

Authors:  Jie Dong; Song Li; Jing-Lin Mo; Huai-Bin Cai; Wei-Dong Le
Journal:  CNS Neurosci Ther       Date:  2016-03-25       Impact factor: 5.243

2.  Efficient Generation of Dopamine Neurons by Synthetic Transcription Factor mRNAs.

Authors:  Sang-Mi Kim; Mi-Sun Lim; Eun-Hye Lee; Sung Jun Jung; Hee Yong Chung; Chun-Hyung Kim; Chang-Hwan Park
Journal:  Mol Ther       Date:  2017-07-11       Impact factor: 11.454

3.  NR4A2: effects of an "orphan" receptor on sustained attention in a schizophrenic population.

Authors:  Inés Ancín; José A Cabranes; Blanca Vázquez-Álvarez; José Luis Santos; Eva Sánchez-Morla; Maaike Alaerts; Jurgen Del-Favero; Ana Barabash
Journal:  Schizophr Bull       Date:  2012-01-31       Impact factor: 9.306

4.  Nurr1 blocks the mitogenic effect of FGF-2 and EGF, inducing olfactory bulb neural stem cells to adopt dopaminergic and dopaminergic-GABAergic neuronal phenotypes.

Authors:  Eva Vergaño-Vera; Eva Díaz-Guerra; Eva Rodríguez-Traver; Héctor R Méndez-Gómez; Óscar Solís; Jaime Pignatelli; James Pickel; Sang-Hun Lee; Rosario Moratalla; Carlos Vicario-Abejón
Journal:  Dev Neurobiol       Date:  2014-12-10       Impact factor: 3.964

5.  Generation of Dopamine Neurons from Rodent Fibroblasts through the Expandable Neural Precursor Cell Stage.

Authors:  Mi-Sun Lim; Mi-Yoon Chang; Sang-Mi Kim; Sang-Hoon Yi; Haeyoung Suh-Kim; Sung Jun Jung; Min Jung Kim; Jin Hyuk Kim; Yong-Sung Lee; Soo Young Lee; Dong-Wook Kim; Sang-Hun Lee; Chang-Hwan Park
Journal:  J Biol Chem       Date:  2015-05-28       Impact factor: 5.157

6.  Conditions for tumor-free and dopamine neuron-enriched grafts after transplanting human ES cell-derived neural precursor cells.

Authors:  Ji-Yun Ko; Hyun-Seob Lee; Chang-Hwan Park; Hyun-Chul Koh; Yong-Sung Lee; Sang-Hun Lee
Journal:  Mol Ther       Date:  2009-07-14       Impact factor: 11.454

7.  Tissue engineered nigrostriatal pathway for treatment of Parkinson's disease.

Authors:  Laura A Struzyna; Kevin D Browne; Zachary D Brodnik; Justin C Burrell; James P Harris; H Isaac Chen; John A Wolf; Kate V Panzer; James Lim; John E Duda; Rodrigo A España; D Kacy Cullen
Journal:  J Tissue Eng Regen Med       Date:  2018-06-03       Impact factor: 3.963

8.  The lentiviral-mediated Nurr1 genetic engineering mesenchymal stem cells protect dopaminergic neurons in a rat model of Parkinson's disease.

Authors:  Xiaoxiao Wang; Wenxin Zhuang; Wenyu Fu; Xiaocui Wang; E Lv; Fengjie Li; Shuanhu Zhou; Wolf-Dieter Rausch; Xin Wang
Journal:  Am J Transl Res       Date:  2018-06-15       Impact factor: 4.060

9.  Role of Nurr1 in the Generation and Differentiation of Dopaminergic Neurons from Stem Cells.

Authors:  Eva Rodríguez-Traver; Oscar Solís; Eva Díaz-Guerra; Óscar Ortiz; Eva Vergaño-Vera; Héctor R Méndez-Gómez; Patricia García-Sanz; Rosario Moratalla; Carlos Vicario-Abejón
Journal:  Neurotox Res       Date:  2015-12-17       Impact factor: 3.911

10.  Generation of dopamine neurons with improved cell survival and phenotype maintenance using a degradation-resistant nurr1 mutant.

Authors:  A-Young Jo; Mi-Young Kim; Hyun-Seob Lee; Yong-Hee Rhee; Jeong-Eun Lee; Kwang-Hyun Baek; Chang-Hwan Park; Hyun-Chul Koh; Incheol Shin; Yong-Sung Lee; Sang-Hun Lee
Journal:  Stem Cells       Date:  2009-09       Impact factor: 6.277

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.